Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway

Lv,Tao; Zhang,Wenjing; Han,Xiaoli

doi:10.3892/ol.2018.8335

Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway

Authors:
- Tao Lv
- Wenjing Zhang
- Xiaoli Han
View Affiliations

Affiliations: Department of General Surgery, Yantai Yeda Hospital, Yantai, Shandong 264006, P.R. China
Published online on: March 23, 2018 https://doi.org/10.3892/ol.2018.8335
Pages: 7603-7610
Copyright: © Lv et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Zerumbone is an active component of Zingiber zerumbet (L.) Smith and can perform a diverse range of antitumor activities. However, the underlying molecular mechanisms of zerumbone action have not yet been elucidated. The aim of the present study was to investigate the antitumor effects, and the associated molecular mechanisms, of zerumbone in hepatoma HepG2 cells. Treatment with zerumbone markedly induced apoptosis in hepatoma HepG2 cells and suppressed their invasion and metastasis in a dose‑dependent manner. Further investigation revealed that treatment with zerumbone led to the dose‑dependent induction of apoptosis and cell cycle arrest at G2/M phase in cancer cells. Zerumbone treatment led to the increased expression of p27, cytochrome c, caspase‑3 and‑9, and Bcl‑2‑associated X expression, but the decreased expression of cyclin‑dependent kinase 1, cyclin B1, B‑cell lymphoma‑2, focal adhesion kinase, Ras homolog gene family, member A, Rho‑associated protein kinase‑1, and matrix metalloproteinase‑2 and‑9 in HepG2 cells. In addition, the phosphorylation of p38 mitogen‑activated protein kinase and extracellular signal‑regulated kinase 1/2, but not C‑Jun N‑terminal kinase 1/2, was regulated in a dose‑dependent manner in response to zerumbone treatment. The results of the current study indicate that zerumbone could be used as potential anticancer agent in for the treatment of hepatoma in the future.

View Figures

View References

1	Gong Q, Qin Z and Hou F: Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation. Oncol Lett. 14:7045–7048. 2017.PubMed/NCBI
2	Qiu X, Huang Y, Zhou Y and Zheng F: Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication. Oncol Rep. 36:811–818. 2016. View Article : Google Scholar : PubMed/NCBI
3	Huang Y, Chen SW, Fan CC, Ting LL, Kuo CC and Chiou JF: Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma. Radiat Oncol. 11:892016. View Article : Google Scholar : PubMed/NCBI
4	Xiao Y, Tian Q, He J, Huang M, Yang C and Gong L: MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor. Onco Targets Ther. 9:3535–3544. 2016.PubMed/NCBI
5	Yoo T, Lee KW, Yi NJ, Choi YR, Kim H, Suh SW, Jeong JH, Lee JM and Suh KS: Peri-transplant change in AFP level: A useful predictor of hepatocellular carcinoma recurrence following liver transplantation. J Korean Med Sci. 31:1049–1054. 2016. View Article : Google Scholar : PubMed/NCBI
6	Sun J, Liu BR, Hu WJ, Yu LX and Qian XP: In vitro anticancer activity of aqueous extracts and ethanol extracts of fifteen traditional Chinese medicines on human digestive tumor cell lines. Phytother Res. 21:1102–1104. 2007. View Article : Google Scholar : PubMed/NCBI
7	Hsiao WL and Liu L: The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights. Planta Med. 76:1118–1131. 2010. View Article : Google Scholar : PubMed/NCBI
8	Sun YW, Qiu HC, Ou MC, Chen RL and Liang G: Saponins isolated from Schizocapsa plantaginea inhibit human hepatocellular carcinoma cell growth in vivo and in vitro via mitogen-activated protein kinase signaling. Chin J Nat Med. 16:29–40. 2018.PubMed/NCBI
9	Pan JX, Chen G, Li JJ, Zhu QD, Li JJ, Chen ZJ, Yu ZP and Ye LY: Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma. Am J Cancer Res. 8:154–164. 2018.PubMed/NCBI
10	Kitayama T: Attractive reactivity of a natural product, zerumbone. Biosci Biotechnol Biochem. 75:199–207. 2011. View Article : Google Scholar : PubMed/NCBI
11	Rahman HS, Rasedee A, Yeap SK, Othman HH, Chartrand MS, Namvar F, Abdul AB and How CW: Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. Biomed Res Int. 2014:9207422014. View Article : Google Scholar : PubMed/NCBI
12	Kirana C, McIntosh GH, Record IR and Jones GP: Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer. 45:218–225. 2003. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Sobenin IA, Bobryshev YV, Korobov GA, Borodachev EN, Postnov AY and Orekhov AN: Quantitative analysis of the expression of caspase 3 and caspase 9 in different types of atherosclerotic lesions in the human aorta. Exp Mol Pathol. 99:1–6. 2015. View Article : Google Scholar : PubMed/NCBI
15	Chen L, Liu H, Liu J, Zhu Y, Xu L, He H, Zhang H, Wang S, Wu Q, Liu W, et al: Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma. PLoS One. 8:e584132013. View Article : Google Scholar : PubMed/NCBI
16	Poortahmasebi V, Poorebrahim M, Najafi S, Jazayeri SM, Alavian SM, Arab SS, Ghavami S, Alavian SE, Moghadam Rezaei A and Amiri M: How hepatitis C virus leads to hepatocellular carcinoma: A network-based study. Hepat Mon. 16:e360052016. View Article : Google Scholar : PubMed/NCBI
17	Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C and Kroemer G: Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13:1423–1433. 2006. View Article : Google Scholar : PubMed/NCBI
18	Antonsson B: Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem. 256–257:141–155. 2004. View Article : Google Scholar
19	Deng Y, Lin Y and Wu X: TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16:33–45. 2002. View Article : Google Scholar : PubMed/NCBI
20	Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 9:541–573. 1993. View Article : Google Scholar : PubMed/NCBI
21	Chang CT, Weng WH, Chou AS, Chuang CK, Porwit-McDonald A, Pang ST, Larsson C and Liao SK: Immunophenotypic and molecular cytogenetic features of the cell line UP-LN1 established from a lymph node metastasis of a poorly-differentiated carcinoma. Anticancer Res. 25:683–691. 2005.PubMed/NCBI
22	Lin HJ, Su CC, Lu HF, Yang JS, Hsu SC, Ip SW, Wu JJ, Li YC, Ho CC, Wu CC and Chung JG: Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2,-9, FAK, Rho A and Rock-1 gene expression. Oncol Rep. 23:665–670. 2010.PubMed/NCBI
23	Ren XD, Kiosses WB and Schwartz MA: Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:578–585. 1999. View Article : Google Scholar : PubMed/NCBI
24	Shi H, Cheng Y, Ye J, Cai P, Zhang J, Li R, Yang Y, Wang Z, Zhang H, Lin C, et al: bFGF promotes the migration of human dermal fibroblasts under diabetic conditions through reactive oxygen species production via the PI3K/Akt-Rac1-JNK pathways. Int J Biol Sci. 11:845–859. 2015. View Article : Google Scholar : PubMed/NCBI
25	Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G and Jiang Y: HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget. 7:14429–14440. 2016.PubMed/NCBI
26	Bauvois B: New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
27	Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
28	Shi L, Lin Q, Yang T, Nie Y, Li X, Liu B, Shen J, Liang Y, Tang Y and Luo F: Oral administration of Lentinus edodes β-glucans ameliorates DSS-induced ulcerative colitis in mice via MAPK-Elk-1 and MAPK-PPARγ pathways. Food Funct. 7:4614–4627. 2016. View Article : Google Scholar : PubMed/NCBI